Cinacalcet lowers FGF-23 level together with bone metabolism in hemodialyzed patients with secondary hyperparathyroidism

被引：0
|
作者：
Tomasz Hryszko
Szymon Brzosko
Alicja Rydzewska-Rosolowska
Ewa Koc-Zorawska
Michal Mysliwiec
机构：
[1] Medical University of Bialystok,Department of Nephrology and Transplantation
来源：
International Urology and Nephrology | 2012年 / 44卷
关键词：
Bone metabolism; Cinacalcet; FGF-23; Hemodialysis; Secondary hyperparathyroidism;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1479 / 1486
页数：7
相关论文
共 43 条
  • [31] Assessment of Clinical Utility of Assaying FGF-23, Klotho Protein, Osteocalcin, NTX, and Sclerostin in Patients with Primary Hyperparathyroidism
    Sykala, Monika
    Szumowski, Piotr
    Mojsak, Malgorzata
    Abdelrazek, Saeid
    Zukowski, Lukasz
    Lipinska, Danuta
    Juchnicka, Ilona
    Kozlowska, Gabryela
    Szelachowska, Malgorzata
    Kretowski, Adam
    Mysliwiec, Janusz
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (14)
  • [32] A randomised controlled trial to examine the effects of cinacalcet on bone and cardiovascular parameters in haemodialysis patients with advanced secondary hyperparathyroidism
    Helen Eddington
    Rajkumar Chinnadurai
    Helen Alderson
    Sara T. Ibrahim
    Constantina Chrysochou
    Darren Green
    Ibi Erekosima
    Alastair Hutchison
    Abdalla Bubtana
    Janet Hegarty
    Philip A. Kalra
    BMC Nephrology, 22
  • [33] A randomised controlled trial to examine the effects of cinacalcet on bone and cardiovascular parameters in haemodialysis patients with advanced secondary hyperparathyroidism
    Eddington, Helen
    Chinnadurai, Rajkumar
    Alderson, Helen
    Ibrahim, Sara T.
    Chrysochou, Constantina
    Green, Darren
    Erekosima, Ibi
    Hutchison, Alastair
    Bubtana, Abdalla
    Hegarty, Janet
    Kalra, Philip A.
    BMC NEPHROLOGY, 2021, 22 (01)
  • [34] Effects of parathyroidectomy on bone metabolism in haemodialysis patients with secondary hyperparathyroidism
    Ma, Lijie
    Zhao, Sumei
    Li, Zhongxin
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2017, 77 (07) : 527 - 534
  • [35] Two Years of Cinacalcet Hydrochloride Treatment Decreased Parathyroid Gland Volume and Serum Parathyroid Hormone Level in Hemodialysis Patients With Advanced Secondary Hyperparathyroidism
    Yamada, Shunsuke
    Tokumoto, Masanori
    Taniguchi, Masatomo
    Toyonaga, Jiro
    Suehiro, Takaichi
    Eriguchi, Rieko
    Fujimi, Satoru
    Ooboshi, Hiroaki
    Kitazono, Takanari
    Tsuruya, Kazuhiko
    THERAPEUTIC APHERESIS AND DIALYSIS, 2015, 19 (04) : 367 - 377
  • [36] Circulating osteoprotegerin affects bone metabolism in dialysis patients with mild secondary hyperparathyroidism
    Kazama, Junichiro James
    Omori, Kentaro
    Yamamoto, Suguru
    Ito, Yumi
    Maruyama, Hiroki
    Narita, Ichiei
    Gejyo, Fumitake
    Iwasaki, Yoshiko
    Fukagawa, Masafumi
    THERAPEUTIC APHERESIS AND DIALYSIS, 2006, 10 (03) : 262 - 266
  • [37] Bone metabolism markers and hungry bone syndrome after parathyroidectomy in dialysis patients with secondary hyperparathyroidism
    Yifei Ge
    Guang Yang
    Ningning Wang
    Xiaoming Zha
    Xiangbao Yu
    Huijuan Mao
    Bin Sun
    Ming Zeng
    Bo Zhang
    Changying Xing
    International Urology and Nephrology, 2019, 51 : 1443 - 1449
  • [38] Bone metabolism markers and hungry bone syndrome after parathyroidectomy in dialysis patients with secondary hyperparathyroidism
    Ge, Yifei
    Yang, Guang
    Wang, Ningning
    Zha, Xiaoming
    Yu, Xiangbao
    Mao, Huijuan
    Sun, Bin
    Zeng, Ming
    Zhang, Bo
    Xing, Changying
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2019, 51 (08) : 1443 - 1449
  • [39] Parathyroidectomy for the attainment of NKF-K/DOQI™ and KDIGO recommended values for bone and mineral metabolism in dialysis patients with uncontrollable secondary hyperparathyroidism
    Kovacevic, Bojan
    Ignjatovic, Mile
    Zivaljevic, Vladan
    Cuk, Vladimir
    Scepanovic, Milena
    Petrovic, Zaklina
    Paunovic, Ivan
    LANGENBECKS ARCHIVES OF SURGERY, 2012, 397 (03) : 413 - 420
  • [40] The influence of intravenous 1,25(OH)2D3 therapy on glucose metabolism in hemodialyzed patients with secondary hyperparathyroidism
    Strózecki, P
    Kretowicz, M
    Odrowaz-Sypniewska, G
    Manitius, J
    RENAL FAILURE, 2004, 26 (04) : 345 - 348
12345